Literature DB >> 26009560

Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.

Sarah Haseltine Van Tassel1, Mrinali P Gupta1, Anton Orlin1, Nancy M Nealon1, Sarju S Patel2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26009560     DOI： 10.1212/WNL.0000000000001611

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

Authors:  Gregory Heath; Archana Airody; Richard Peter Gale
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab.

Authors:  Arjun B Sood; Gokul Kumar; Joshua Robinson
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-07-20

3.  An experimental study to evaluate safety/toxicity of intravitreal natalizumab.

Authors:  Rohan Chawla; Madhu Nath; Laxmi Moksha; Tapas C Nag; Thirumurthy Velpandian
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.